Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mirati Therapeutics (NQ: MRTX ) 58.70 UNCHANGED Last Price Updated: 4:00 PM EST, Jan 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Mirati Therapeutics < Previous 1 2 3 4 5 6 7 Next > Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 December 29, 2023 According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023. Via Benzinga EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday December 20, 2023 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga Analyst Expectations For Mirati Therapeutics's Future December 20, 2023 Via Benzinga 3 Resilient Stocks with Massive Potential to Boost Your Wealth November 26, 2023 These three stocks with massive potential can make patient investors fabuslously wealthy as they come roaring back to life. Via InvestorPlace What 11 Analyst Ratings Have To Say About Mirati Therapeutics November 07, 2023 Via Benzinga What's Going On With Mirati Therapeutics Stock? October 06, 2023 Mirati Therapeutics, Inc. (NASDAQ: MRTX) shares are trading higher Friday. Via Benzinga These Three Biotech Stocks Are Trading At A Discount November 23, 2023 Investors exposed to the biotech sector have seen mixed results this year. Via Talk Markets 10 Health Care Stocks With Whale Alerts In Today's Session November 17, 2023 Via Benzinga 3 Biotech Stocks That Could Boom or Bust by 2025 November 16, 2023 Biotech stocks are popular with investors because they sometimes provide tremendous rewards. Here are three to buy for a potential payday. Via InvestorPlace 3 No-Brainer Stocks to Buy With $500 Right Now November 08, 2023 A reasonably modest amount of money can go a long way when it's invested in time-tested businesses with sustained catalysts. Via The Motley Fool Appian To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Tuesday November 07, 2023 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page Via Benzinga Is MIRATI THERAPEUTICS INC Ready to Break Out of Its Range? November 06, 2023 Investors are keeping a close eye on MIRATI THERAPEUTICS INC (NASDAQ:MRTX) as it boasts an impressive technical rating of 7 out of 10, signaling a possible breakout. Via Chartmill 7 Healthcare Stocks That Can Cure a Lackluster Portfolio October 19, 2023 Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio. Via InvestorPlace Opdivo's Subcutaneous Formulation Shows Promise in Advanced Kidney Cancer: Bristol Myers Squibb's Latest Findings October 19, 2023 Bristol Myers Squibb Co (NYSE: BMY) released topline data from the Phase 3 CheckMate -67T noninferiority trial of a subcutaneous Opdivo (nivolumab) compared to intravenous (IV) Opdivo for advanced or... Via Benzinga Amgen Stock Surges To 10-Month High, Up 4% On An Unexpected Upgrade October 11, 2023 The company has growing pipeline optionality, according to the upgrade report. Via Investor's Business Daily Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023 October 10, 2023 Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session October 09, 2023 Via Benzinga Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session October 09, 2023 Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near... Via Benzinga Why Shares of Tango Therapeutics Are Dropping Monday October 09, 2023 Another company's buyout helped drive up the price last week. This week, investors started out by selling the stock. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023 October 09, 2023 Via Benzinga Mirati Therapeutics Snags $5.8 Billion Takeover Deal, But Shares Fall On Lowball Bid October 09, 2023 Bristol Myers Squibb hopes to buy Mirati Therapeutics for up to $5.8 billion. Via Investor's Business Daily Bristol Myers Squibb Strengthens Oncology Portfolio With Mirati Therapeutics' $5B Deal October 09, 2023 Bristol Myers Squibb & Co (NYSE: BMY) has agreed to acquire Mirati Therapeutics Inc (NASDAQ: MRTX) for $58.00 per share in cash, for a total Via Benzinga S&P 500, Nasdaq Set For Bleak Start To Week As Middle East Tensions Dampen Risk-On Mood: Earnings, Inflation Data In Focus October 09, 2023 Trading in stock futures suggests a lower open on Monday as traders digest the ramification of the conflict in the Middle East. Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Tesla, Mirati Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session October 09, 2023 U.S. stock futures traded lower this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga Amgen's Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics' Lung Cancer Drug: Analysts October 06, 2023 According to a report on Thursday, French pharma company Sanofi SA (NASDAQ: SNY) is reportedly exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc (NASDAQ: MRTX). Via Benzinga FDA Adcomm Gives Thumbs Down To Amgen's Lumakras For Advanced Form Of Lung Cancer October 06, 2023 FDA advisers concluded that the data from a late-stage trial lacked the requisite reliability to endorse the traditional approval of Amgen Inc's (NASDAQ: AMGN) Lumakras for patients afflicted with an... Via Benzinga Exposures Product Safety 3 Under-the-Radar Biotech Stocks to Buy in 2023 August 19, 2023 All three biotech companies focus on oncology therapies. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023 August 10, 2023 Via Benzinga Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session August 09, 2023 Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. Via Benzinga Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday August 09, 2023 U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.